• Lutte contre les cancers

  • Sensibilisation et communication

  • Col de l'utérus

Lack of awareness of human papillomavirus testing among U.S. women

Menée à partir de données de 3 enquêtes réalisées entre 2017 et 2019 auprès de millions de femmes américaines, cette étude analyse leur connaissance du dépistage du papillomavirus humain (HPV)

Introduction: National surveys provide important information for public health planning. Lack of preventive screenings awareness may result in unreliable survey estimates. This study examines women's awareness of receiving human papillomavirus (HPV) testing using three national surveys. Methods: In 2022, self-reported data analyses on HPV testing status among women without hysterectomy were conducted from the 2020 Behavioral Risk Factor Surveillance System [BRFSS, n=80648, (aged 30-64 years)], the 2019 National Health Interview Survey [NHIS, n=7062, (aged 30-65 years)], and the 2017-2019 National Survey of Family Growth [NSFG, n=2973, (aged 30-49 years)]. Associations between HPV awareness status, (yes, no, don't know) and demographic characteristics were examined with generalized multinomial logistic model to generate adjusted prevalence ratios (APR). Adjusted risk differences were assessed with the t-test for the Don't know answer. Results: 21.8%, or over 12 million in the study population of women in BRFSS, 19.5%, (over 10.5 million women) in NHIS, and 9.4% in NSFG responded “don't know” to HPV testing awareness status question. Women aged 40–64 years in BRFSS and 50–65 years in NHIS were more likely to answer “don't know” than those aged 30-34 (p<0.05 and p<.01, respectively). Non-Hispanic (NH) White women were more likely to answer “don't know” than NH Native Hawaiian/Pacific Islander (NHPI), NH Black, NH Asian, and Hispanic women in BRFSS and NH Black women in NHIS [(APR range: 0.60 to 0.78; p<.001) and (APR=0.72; p<.001) respectively]. Conclusions: One in five women was unaware of her HPV testing status, and awareness was lower among older and NH White women. The awareness gap may affect reliability of estimated HPV testing population uptake using survey data.

American Journal of Preventive Medicine 2022

View the bulletin